TAVR has emerged as a revolutionary treatment for patients with severe aortic stenosis. Over the past decade, this minimally invasive procedure has evolved rapidly, with improvements in device design, procedural techniques, and patient selection.

​

However, as TAVR has become more widely adopted, new challenges and areas of debate have also surfaced. These include the optimal patient population for TAVR, the long-term durability of TAVR valves, the management of complications, and the role of TAVR versus surgical aortic valve replacement.

​

In this seminar, we have assembled a panel of distinguished experts who will provide insights into the current state of TAVR, discuss the latest clinical evidence, and explore the key controversies surrounding this transformative technology.